Stryker Corp
NYSE:SYK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hindustan Oil Exploration Company Ltd
NSE:HINDOILEXP
|
IN |
Stryker Corp
Accounts Payable
Stryker Corp
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$1.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accounts Payable
$227.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Accounts Payable
$110.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$255.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
17%
|
|
Stryker Corp
Glance View
Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.
See Also
What is Stryker Corp's Accounts Payable?
Accounts Payable
1.8B
USD
Based on the financial report for Dec 31, 2025, Stryker Corp's Accounts Payable amounts to 1.8B USD.
What is Stryker Corp's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
16%
Over the last year, the Accounts Payable growth was 7%. The average annual Accounts Payable growth rates for Stryker Corp have been 8% over the past three years , 17% over the past five years , and 16% over the past ten years .